What products does Gilead Sciences offer?

Gilead Sciences offers a diverse portfolio of pharmaceutical products aimed at addressing a wide range of diseases and conditions. We specialize in developing innovative treatments to combat life-threatening illnesses including HIV, hepatitis B and C, liver diseases, cancer, and respiratory tract infections. Our flagship products include Truvada, Atripla, and Biktarvy, which are groundbreaking antiretroviral therapies that significantly improve the lives of people living with HIV. We also offer Harvoni and Epclusa, highly efficient medications for the treatment of chronic hepatitis C, and Letairis, a groundbreaking treatment for pulmonary arterial hypertension. Furthermore, Gilead Sciences continuously invests in cutting-edge research and development to bring new treatment options to patients in need worldwide.